PNPLA3 and portal hypertension: Moreover, the coexistence of both the PNPLA3 G allele and SERPINA1 Pi*Z variant further amplified the risk of ACLD and CSPH, highlighting a synergistic effect of these genetic variants in the progression of liver disease and portal hypertension [65].